Geneva Advisors’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
Other funds holding PODD
SPC
FCM
VM
Geneva Advisors's PODD Position: Q2 2017 in Review
Geneva Advisors increased its Insulet (PODD) stake by 2.3% in Q2 2017, buying an estimated $21.9K and bringing the position to 22,215 shares worth $1.14M. The position accounts for 0.02% of the portfolio, ranked #338.
Geneva Advisors first reported a position in PODD in Q2 2013 and has held it in 17 quarters since. The position peaked at $23.5M in Q1 2014. 162 funds tracked by Wall St. Rank hold PODD as of Q2 2017.
- Geneva Advisors held 22,215 shares of Insulet worth $1.14M as of Q2 2017.
- Geneva Advisors bought 504 Insulet shares in Q2 2017, an estimated $21.9K.
- Insulet made up 0.02% of Geneva Advisors's portfolio in Q2 2017, its #338 holding.
- Geneva Advisors first reported a position in Insulet in Q2 2013 and has held it in 17 quarters since.
- Geneva Advisors's Insulet position peaked at $23.5M in Q1 2014.
- 162 funds tracked by Wall St. Rank held Insulet as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.